Affordable Access

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

Authors
  • 1
  • 1 Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA. [email protected]
Type
Published Article
Journal
JNCI Journal of the National Cancer Institute
1460-2105
Publisher
Oxford University Press
Publication Date
Volume
97
Issue
17
Pages
1262–1271
Identifiers
PMID: 16145047
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments